• genOway provides the necessary intellectual property rights to use these models, including the IRES or Homologous Recombination exclusive technologies

• The agreement enables short timespans to access EUCOMM / EUCOMMTOOLS materials and generate conditional KO models from them

The industry will strongly benefit from this new genOway offer as its R&D saves months in obtaining conditional KO models and the necessary intellectual property rights at the same time. Direct access to EUCOMM mice via the EMMA repository will significantly reduce the time required to develop conditional KO models. The EMMA repository, via the INFRAFRONTIER platform, facilitates access to a large collection of EUCOMM mice that are widely used by the biomedical community.